Skip to content

Efficacy and Safety of corticosteroids and vigabatrin plus corticosteroids in infantile spasm

Comparison of efficacy and safety of corticosteroids and vigabatrin plus corticosteroids in infantile spasm: An open label randomized control trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200414047072N2
Enrollment
320
Registered
2020-11-06
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile spasm. Epileptic spasms, not intractable, without status epilepticus

Interventions

Intervention 1: Intervention group 1: Children will be divided into two groups by random allocation for the selection of treatment protocol. Group A children will receive prednisolone 40 mg/day in 4 d

Sponsors

The Children's Hospital & the Institute of Child Health, Multan.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 12 Months

Inclusion criteria

Inclusion criteria: Signed informed consent from parents/guardians Children aged one to 12 months Both genders with clinical diagnosis of infantile spasm made according to international league against epilepsy plus hypsarrhythmia on EEG (EEG records were graded using the Burden of Amplitudes and Epileptiform Discharges (BASED) scoring system

Exclusion criteria

Exclusion criteria: Infantile spasm due to tuberous sclerosis Previous treatment with steroids or vigabatrin Contraindication to steroids/vigabatrin (fever, active infection and hypertension).

Design outcomes

Primary

MeasureTime frame
Electroclinical remission (cessation of spasms plus resolution ofhypsarrhythmia). Timepoint: Before intervention and Day 4, 7, 14, 21, 28, 42, 60, 90, 120, 150 and day 180. Method of measurement: Fundoscopy and blood pressure.;EEG will be performed at day 0, 14, 42, 60, 90 and 180. Sleep EEG will be recorded for a minimum duration of 30 minutes according to international 10-20 system of electrode placement. Timepoint: day 0, 14, 42, 60, 90 and 180. Method of measurement: Burden of Amplitudes and Epileptiform Discharges (BASED) scoring system.;Developmental assessment. Timepoint: day 0, 90 and 180. Method of measurement: portage early education program (PEEP).

Countries

Pakistan

Contacts

Public ContactDr. Nuzhat Noureen

The Children's Hospital & the Institute of Child Health, Multan.

drnuzhatrana@gmail.com+92 61 9201431

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026